No Data
No Data
Does Apeloa PharmaceuticalLtd (SZSE:000739) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it
Apeloa Pharmaceutical (000739.SZ): has repurchased 0.88% of shares.
Apeloa Pharmaceutical (000739.SZ) announced that as of June 30, 2024, the company has repurchased 10,325,000 shares of the company through a repurchase special securities account in the manner of centralized bidding trading, accounting for 0.88% of the company's current total share capital. The highest fill price was 15 yuan/share and the lowest fill price was 12.64 yuan/share. The total transaction amount was RMB 145,650,171 (excluding transaction costs).
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Stock Is Going Strong: Is the Market Following Fundamentals?
Apeloa PharmaceuticalLtd (SZSE:000739) has had a great run on the share market with its stock up by a significant 12% over the last three months. Given the company's impressive performance, we decid
Apeloa Pharmaceutical (000739.SZ) has spent a total of 79,799,200 yuan to repurchase 5,735,000 shares.
Apeloa Pharmaceutical (000739.SZ) announced on June 3rd that as of May 31, 2024, the company has repurchased 5,735,000 shares of the company through a repurchase special securities account in a centralized bidding trading manner, accounting for 0.49% of the total share capital, with a maximum fill price of 14.98 yuan/share, a minimum fill price of 12.64 yuan/share, and a total transaction amount of RMB 79,799,189 (excluding transaction fees).
Investors in Apeloa PharmaceuticalLtd (SZSE:000739) Have Seen Respectable Returns of 69% Over the Past Five Years
When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is one path to excess returns. For example, the Apeloa Pharmaceutical Co.,Ltd (SZ
Pro-Pharmaceuticals (000739.SZ): 2023 10 dividends of 3.169 yuan Equity registration date May 22
On May 15, GLONGHUI Pharmaceuticals (000739.SZ) announced that the company's 2023 dividend payment plan is to distribute RMB 3.16,9086 in cash (including tax) for every 10 shares to all shareholders who can participate in the distribution, based on 1,165,971,076 shares after excluding 12,552,416 shares of the company's existing total share capital. The share registration date for this dividend payment is May 22, 2024; the excluding dividend date is May 23, 2024.
No Data